Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adalimumab (humira) (2 trials)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Trials (2 total)
Trial APIs (1 total)